Grant

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

CountryUnited States
Deadline2027-03-05 (103 days left)
Published2024-01-17
SectorsHealth & life sciences, Research & innovation
SourceGrants.gov (US)

Summary

Funding opportunity RFA-DA-25-060. CFDA: 93.279

The buyer, the value, the full description and the link to the official notice are available with a free account.